Injection, octreotide, depot form for intramuscular injection, 1 mg
HCPCS code
Name of the Procedure:
Injection, octreotide, depot form for intramuscular injection, 1 mg
Common name: Octreotide Injection
Technical/medical term: Depot Octreotide Injection
Summary
This procedure involves the administration of a medication called octreotide in a long-acting depot form through an intramuscular injection. Octreotide is used to treat various medical conditions by mimicking natural hormones in the body.
Purpose
Octreotide injections are used to treat symptoms associated with certain cancers, such as carcinoid tumors and VIPomas (vasoactive intestinal peptide-secreting tumors), as well as acromegaly, a condition in which the body produces too much growth hormone. The goal is to manage symptoms and control hormone secretion for improved quality of life.
Indications
- Symptomatic carcinoid tumors
- VIPomas
- Acromegaly Patients with these conditions who do not respond to other treatments or for whom surgery is not an option may be appropriate candidates.
Preparation
- Fasting: Not typically required.
- Medication Adjustments: Follow the healthcare provider’s instructions on any medication changes.
- Diagnostic Tests: Blood tests to measure hormone levels and diagnostic imaging may be performed to confirm the diagnosis and evaluate the extent of the condition.
Procedure Description
- Preparation: The healthcare professional prepares the depot form of octreotide.
- Injection Site: The injection is administered into a large muscle, typically the gluteal muscle.
- Injection: A healthcare provider uses a syringe to deliver the medication deeply into the muscle.
- Monitoring: The patient is observed briefly after the injection for any adverse reactions.
Tools used include a sterile syringe and the depot octreotide formulation. Anesthesia is not usually required, but local numbing agents may be used if necessary.
Duration
The injection takes approximately a few minutes to administer. However, the patient may need to stay for observation for an additional 15-30 minutes.
Setting
The procedure is typically performed in an outpatient clinic, doctor's office, or hospital setting.
Personnel
- Healthcare Professional: Physician, Physician Assistant, or Nurse
- Supporting Staff: Nurse or Medical Assistant for preparation and monitoring
Risks and Complications
- Common Risks: Pain at the injection site, mild swelling or bruising
- Rare Risks: Allergic reactions, infection at the injection site, gastrointestinal disturbances Any complications are usually managed with appropriate medical treatment and follow-up care.
Benefits
- Symptom Relief: Reduces symptoms like diarrhea, flushing, and hormone secretion abnormalities.
- Improved Quality of Life: Long-term control of symptoms aids in daily functioning and comfort.
- Benefits may be realized within a few days to a few weeks.
Recovery
- Post-Procedure: Patients can usually return to normal activities immediately.
- Instructions: Keep the injection site clean and monitor for any signs of infection.
- Follow-Up: Regular follow-up appointments are necessary to monitor hormone levels and symptoms.
Alternatives
- Medications: Short-acting octreotide injections or other hormone inhibitors.
- Surgery: In some cases, surgery to remove the tumor.
- Pros and Cons: Alternatives may require more frequent dosing or be associated with different side effects.
Patient Experience
- During the Procedure: Slight discomfort or pain at the injection site.
- After the Procedure: Some soreness or mild bruising may occur. Pain can be managed with over-the-counter pain relievers if necessary. Patients generally experience relief from symptoms within a few days to weeks.